A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis.
about
Intestinal microbiota transplant - current state of knowledgeMucosal Interactions between Genetics, Diet, and Microbiome in Inflammatory Bowel DiseaseThe Gut Microbiota in Immune-Mediated Inflammatory DiseasesThe intestinal microbiome, barrier function, and immune system in inflammatory bowel disease: a tripartite pathophysiological circuit with implications for new therapeutic directionsIntestinal Short Chain Fatty Acids and their Link with Diet and Human HealthTherapeutic Potential to Modify the Mucus Barrier in Inflammatory Bowel DiseaseMechanisms of Microbe-Host Interaction in Crohn's Disease: Dysbiosis vs. Pathobiont SelectionMolecular Players Involved in the Interaction Between Beneficial Bacteria and the Immune SystemMicrobiota-Specific CD4CD8αα Tregs: Role in Intestinal Immune Homeostasis and Implications for IBDIntestinal Microbiota in Animal Models of Inflammatory DiseasesIntestinal microbiota pathogenesis and fecal microbiota transplantation for inflammatory bowel diseaseIntestinal permeability--a new target for disease prevention and therapyMicrobiome, Metabolome and Inflammatory Bowel DiseaseIntestinal Permeability in Inflammatory Bowel Disease: Pathogenesis, Clinical Evaluation, and Therapy of Leaky GutGut Microbiota and Host Reaction in Liver DiseasesThe Microbiome and Sustainable Healthcare.Oral Administration of Faecalibacterium prausnitzii Decreased the Incidence of Severe Diarrhea and Related Mortality Rate and Increased Weight Gain in Preweaned Dairy HeifersGut microbiota and colorectal cancer.Multilevel regularized regression for simultaneous taxa selection and network construction with metagenomic count data.Mucosa-associated Faecalibacterium prausnitzii phylotype richness is reduced in patients with inflammatory bowel disease.Can we change our microbiome to prevent colorectal cancer development?Differential expression of GPR15 on T cells during ulcerative colitis.Chemical and pathogen-induced inflammation disrupt the murine intestinal microbiome.The role of diet on intestinal microbiota metabolism: downstream impacts on host immune function and health, and therapeutic implications.Multi-targeting therapeutic mechanisms of the Chinese herbal medicine QHD in the treatment of non-alcoholic fatty liver disease.Effects of Commercial Apple Varieties on Human Gut Microbiota Composition and Metabolic Output Using an In Vitro Colonic Model.Comparisons of Gut Microbiota Among Healthy Control, Patients With Conventional Adenoma, Sessile Serrated Adenoma, and Colorectal CancerRoles for Intestinal Bacteria, Viruses, and Fungi in Pathogenesis of Inflammatory Bowel Diseases and Therapeutic Approaches.Potential and active functions in the gut microbiota of a healthy human cohortThe intestinal metabolome: an intersection between microbiota and host.The colonization dynamics of the gut microbiota in tilapia larvae.Escherichia coli in chronic inflammatory bowel diseases: An update on adherent invasive Escherichia coli pathogenicityDifferential responses of cecal microbiota to fishmeal, Eimeria and Clostridium perfringens in a necrotic enteritis challenge model in chickens.Impact of stressor exposure on the interplay between commensal microbiota and host inflammationMetabolic alterations to the mucosal microbiota in inflammatory bowel disease.Multivariate inference of pathway activity in host immunity and response to therapeutics.Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severityEnteric microbiota leads to new therapeutic strategies for ulcerative colitis.Comparison of assembly algorithms for improving rate of metatranscriptomic functional annotationHuman genetics shape the gut microbiome.
P2860
Q26741017-0D307AD9-4CA9-43B6-8B5E-1586FDA33ED9Q26741117-5ED42D01-A48E-4159-AE5D-2493201EDBAEQ26741414-ADAA079F-E0F3-475D-A69F-DA0331075592Q26745700-592B69BF-67B3-4256-BF7B-54B21544B430Q26765857-8621BAF0-4740-4523-95F4-4291B8D1497FQ26771122-16875D0F-3B2C-4BC4-A67F-419B26CAC102Q26774688-4EEB6533-952B-40CF-B3C4-08F16002DFBBQ26774703-4ACF03AE-3D21-4BB3-AF2A-F52170A6FCA7Q26779169-7FDE4782-FB34-41C7-8491-91496161AF8AQ26795707-9AEB31C9-8D56-490A-8465-5D915B64A4B3Q27003192-3992E01F-D80F-4DD9-9BDD-C96C8D93B043Q27015884-BBFB238E-01D0-41DE-86D2-B451A9CB6AFAQ28078126-E46F34FE-8F05-4412-AE0C-C27DDD114E67Q28081848-151B50FC-E166-4FE2-8AD4-5271B9142EABQ28083295-D7CB9168-503E-42CC-ACCF-1928B1D94260Q28088606-A06310BA-42E7-40D5-92C0-FBA380A01116Q28603476-08FB90AA-CF5B-4733-ABD2-4113C081E465Q30239806-FEDAEB53-B5D0-4480-A0BE-8106D90572C9Q30871031-8B88FCBE-0476-4133-9F09-647A108AD9FCQ30988830-BCAB2AF1-BD9A-44F7-95BE-E835365E56C3Q33360917-1C8646F7-D90C-477F-A6C3-356216924934Q33579024-27C1958A-BC1C-4CDC-8EE0-8CF9ADEEA197Q33612677-F933F8E4-E0E3-44E1-A297-AB93AB583D37Q33670800-9F6D7C05-8D67-4B4E-B82C-4BAC1078D44BQ33709456-E52CD688-9A24-4020-85AF-5844FDA265B9Q33851760-07C3C3D1-DEE0-4BF0-B0CD-073704627FA6Q33888089-78DA5A7A-E2D2-4E16-A0F2-131D562D1FF3Q33906911-02886DD7-DC40-44ED-A0F8-DC419D4C98EAQ33909976-E1842C09-5B4D-4C43-94A0-CECA21975918Q33915560-1333302D-9893-49D0-B2B2-03ECA1FC7320Q33968967-B6B01124-04AD-45D1-A25E-8694B3320A36Q34048001-6F3E55E0-1510-4F28-A3DE-395CE3AD3DECQ34104628-03B2FD6A-2148-4B10-B74C-956445C1045DQ34129398-9AEDF789-7448-4677-9750-A20DE2312983Q34153279-9C6A71ED-CB9E-442E-9326-657743D3476FQ34249561-F898ED58-D431-4B26-A17B-4026CDDC5EE1Q34409186-96788B21-6A7E-415C-99A8-B32A332A24D9Q34499080-C330C803-ADC0-43CE-A4B8-D1A929FD2D0FQ34539926-E1C701AF-2E01-4A46-BDD2-1A01CCBAE951Q34630305-D8B56ECA-18D3-4787-B755-48FE7CC6DE29
P2860
A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis.
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
A decrease of the butyrate-pro ...... ients with ulcerative colitis.
@ast
A decrease of the butyrate-pro ...... ients with ulcerative colitis.
@en
A decrease of the butyrate-pro ...... ients with ulcerative colitis.
@nl
type
label
A decrease of the butyrate-pro ...... ients with ulcerative colitis.
@ast
A decrease of the butyrate-pro ...... ients with ulcerative colitis.
@en
A decrease of the butyrate-pro ...... ients with ulcerative colitis.
@nl
prefLabel
A decrease of the butyrate-pro ...... ients with ulcerative colitis.
@ast
A decrease of the butyrate-pro ...... ients with ulcerative colitis.
@en
A decrease of the butyrate-pro ...... ients with ulcerative colitis.
@nl
P2093
P50
P1433
P1476
A decrease of the butyrate-pro ...... ients with ulcerative colitis.
@en
P2093
Jan Verhaegen
João Sabino
Karolien Claes
Kathleen Machiels
Kristin Verbeke
Marc Ferrante
Marie Joossens
Venessa Eeckhaut
Vera Ballet
P304
P356
10.1136/GUTJNL-2013-304833
P407
P577
2013-09-10T00:00:00Z